Beijing Tong Ren Tang Healthcare Investment Co Ltd (Ticker: 2667 HK) is a China-domiciled Traditional Chinese Medicine (TCM) healthcare provider and a subsidiary of the TRT Group. The company delivers a combination of medical treatment and care through a tiered network of 12 self-owned medical institutions, an Internet hospital, and 10 managed offline institutions. As of 2024, it is reportedly the largest TCM hospital group in China’s non-public TCM healthcare service industry by patient visits. Beijing Tong Ren Tang Healthcare plans to list on the Main Board of the Hong Kong Stock Exchange on March 30, 2026.

The company is offering 108.15 million shares with an expected price range of HKD 7.30 to HKD 8.30, aiming to raise approximately HKD 897.67 million (equivalent to USD 114.59 million). Based on the price range, the estimated market capitalization is between USD 435.5 million and USD 495.2 million. According to the prospectus, the proceeds will be used for brand promotion, business development, working capital, strategic acquisitions, and debt repayment. The IPO is sponsored by China International Capital Corporation, with a large underwriting syndicate including ABCI Capital and China Galaxy International.